Johnson & Johnson Quarterly Cash Flow Statement
NYSE: JNJHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Johnson & Johnson free cash flow
In the quarter ended Jun 28, 2026, Johnson & Johnson generated $8.62 billion of operating cash flow and spent $1.32 billion on capital expenditures. That left free cash flow of $7.29 billion, a free-cash-flow margin of 28.8% of revenue. Free cash flow was up 157.3% from the prior year's $2.83 billion.
Johnson & Johnson returned $3.45 billion to shareholders: $3.23 billion in dividends and $221.0 million in share repurchases, equal to 47% of free cash flow. Free cash flow covered dividend payments 2.3 times.
Summary generated from market data by MetaCap's automated system. Methodology
Johnson & Johnson cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-28 | Q1 20262026-03-29 | Q4 20252025-12-28 | Q3 20252025-09-28 | Q2 20252025-06-29 | Q1 20252025-03-30 | Q4 20242024-12-29 | Q3 20242024-09-29 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-10-01 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 5.53B | 5.24B | 5.12B | 5.15B | 5.54B | 11.00B | 3.43B | 2.69B | 4.69B | 3.25B | 4.05B | 26.03B |
| Net Income growth (YoY) | -0.05% | -52.40% | +49.11% | +91.24% | +18.16% | +237.91% | -15.26% | -89.65% | -8.90% | — | +15.03% | +483.85% |
| Depreciation & Amortization | 1.96B | 2.00B | 2.01B | 1.78B | 1.94B | 1.77B | 1.90B | 1.85B | 1.78B | 1.81B | 1.84B | 1.83B |
| Stock-Based Compensation | 458.00M | 300.00M | 309.00M | 347.00M | 410.00M | 288.00M | 238.00M | 295.00M | 341.00M | 302.00M | 178.00M | 296.00M |
| Change in Working Capital | 1.02B | -5.23B | 3.60B | -369.00M | -4.92B | -11.02B | 798.00M | 1.83B | -452.00M | -338.00M | 3.25B | -602.00M |
| Operating Cash Flow | 8.62B | 2.51B | 7.31B | 9.17B | 3.88B | 4.17B | 6.98B | 7.99B | 5.63B | 3.66B | 7.86B | 7.49B |
| Capital Expenditures | -1.32B | -1.05B | -1.84B | -1.16B | -1.04B | -795.00M | -1.61B | -1.03B | -976.00M | -807.00M | -1.59B | -967.00M |
| Investing Cash Flow | -1.11B | -1.04B | -4.49B | -542.00M | -18.26B | -297.00M | -1.32B | -3.13B | -13.69B | -464.00M | -1.20B | 2.54B |
| Dividends Paid | -3.23B | -3.13B | -3.13B | -3.13B | -3.13B | -2.99B | -2.98B | -2.98B | -2.98B | -2.87B | -2.87B | -2.87B |
| Share Repurchases | -221.00M | -4.03B | -1.92B | -1.90B | 0 | -2.13B | -282.00M | -539.00M | -136.00M | -1.48B | -216.00M | -920.00M |
| Debt Issued | 0 | 0 | 0 | 0 | 0 | 9.14B | 0 | 1.00M | 6.66B | 2.00M | 0 | -7.67B |
| Debt Repaid | -1.00M | -2.00B | — | -1.00B | -3.00M | -751.00M | — | -1.00M | -802.00M | -1.00M | -1.05B | -1.00M |
| Financing Cash Flow | -8.78B | 530.00M | -1.37B | -8.93B | -5.67B | 10.42B | -1.34B | -9.88B | 7.54B | 546.00M | -4.66B | -11.32B |
| Net Change in Cash | -1.27B | 1.98B | 1.48B | -346.00M | -19.90B | 14.37B | 4.13B | -4.90B | -595.00M | 3.61B | 2.13B | -1.46B |
| Free Cash Flow | 7.29B | 1.47B | 5.47B | 8.01B | 2.83B | 3.38B | 5.37B | 6.96B | 4.66B | 2.85B | 6.27B | 6.52B |
This table shows 12 quarterly periods of Johnson & Johnson's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow JNJ's reporting calendar. What is a cash flow statement?